Part 4/4:
As the announced tariffs approach, stakeholders across the pharmaceutical sector, importers, and policymakers are likely to closely monitor further developments. The Trump administration’s aggressive tariff strategy signifies a strong push toward domestic manufacturing and national self-reliance in critical industries, though it also raises questions about the economic and diplomatic repercussions of such trade policies.